Bioequivalence Recommendations for Specific Pro­ducts [Regulatives / Guidelines]

posted by cr.maroj – UK, 2013-09-19 13:00 (4666 d 15:59 ago) – Posting: # 11522
Views: 37,223

Hi there,

Could someone please help me with this. Do we get Bioequivalence Recommendations for Specific Products on EMA site, the way they are available on FDA site. (http://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/guidances/ucm075207.htm)

My requirement is, per FDA recommendations for Spironolactone, analytes to be measured for showing BE is just the parent compound. But as we are planning for MHRA submission, I am not sure if MHRA insists on metabolites as well.

Literature shows that, Spironolactone is extensively metabolized; it has three known active metabolites: canrenone, 7-thiomethylspironolactone, and 6-hydroxy-7-thiomethylspironolactone.

Your advise on this will be highly appreciated.

Kind regards
CR

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
273 visitors (0 registered, 273 guests [including 31 identified bots]).
Forum time: 05:00 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5